A new report titled “Spinal Muscular Atrophy Treatment Market – Forecast to 2033” by Eternal Markets, the global spinal muscular atrophy treatment industry is projected to grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2033, reaching a value of USD 8,244.5 million by the end of the forecast period.
Overview
The global spinal muscular atrophy treatment market is witnessing significant growth, driven by the increasing prevalence of spinal muscular atrophy (SMA) and the growing focus on developing effective therapies. SMA is a genetic disorder that affects motor neurons in the spinal cord, leading to muscle weakness and atrophy. The market includes various treatment options such as gene therapy, medications, and supportive care. The rising investment in research and development activities, increasing approval of innovative therapies, and growing awareness of SMA are key factors propelling market growth. North America and Europe are leading markets due to advanced healthcare infrastructure and strong support for rare disease research.
Key Visions
- The market is projected to grow at a CAGR of approximately 7.7% over the forecast period (2024-2033).
- The global SMA treatment industry size is projected to reach USD 8,244.5 million by 2033, up from USD 4,230.3 million in 2023.
- Increasing incidence of SMA and advancements in genetic therapies are key drivers for market growth.
- By Type: In 2023, the Type 1 segment held the largest market share due to the high prevalence and severity of this subtype.
- By Route of Administration: The Parenteral segment is expected to be the largest revenue contributor by 2033, driven by the efficacy of injectable treatments.
- North America held the largest market share in 2023, supported by advanced healthcare infrastructure and significant research investments.
Key Market Drivers
Rising Prevalence: Increasing incidence of spinal muscular atrophy globally, necessitating effective treatment options.
Advancements in Genetic Therapies: Development of novel genetic therapies offering improved patient outcomes.
Government Support: Favorable government policies and funding for SMA research and treatment programs.
Technological Innovations: Continuous advancements in biotechnology and drug development.
Awareness Campaigns: Enhanced awareness among healthcare professionals and the public about SMA and available treatments.
Restraining Factors
High Treatment Costs: Expensive genetic therapies and treatments limiting accessibility.
Regulatory Challenges: Stringent regulatory requirements for the approval of new therapies.
Limited Awareness in Some Regions: Lack of awareness and understanding of SMA in certain regions hindering early diagnosis and treatment.
Access to Care: Variability in healthcare infrastructure affecting treatment availability.
Future Scope
Emerging Markets: Growth opportunities in emerging economies with improving healthcare infrastructure.
Personalized Medicine: Development of personalized therapies tailored to individual genetic profiles.
Telemedicine Expansion: Increased adoption of telemedicine for remote monitoring and management of SMA.
Collaborative Research: Enhanced collaboration between pharmaceutical companies, research institutions, and healthcare providers.
New Therapeutic Approaches: Ongoing research into novel therapeutic approaches and combination therapies.
Major Strategies adopted by key market players.
- Agreements, Collaborations, and Partnerships: 21%
- Acquisitions: 15%
- New Product Launch: _%
- Other Developments: _%
Geographical Analysis
North America: Leading the market due to advanced healthcare infrastructure, significant R&D investments, and strong awareness programs. The U.S. is the major contributor.
Europe: Holds a substantial market share driven by robust healthcare systems, government support, and active research initiatives. Key markets include Germany, the U.K., and France.
Asia-Pacific: Expected to exhibit the highest growth rate, fueled by increasing awareness, improving healthcare infrastructure, and government initiatives. Major markets include China, Japan, and India.
Recent Developments
- Hoffmann-La Roche Ltd.: Launched a new SMA therapy in 2023, expanding its product portfolio.
- Biogen: Acquired a biotechnology company specializing in SMA treatments in 2022, enhancing its market presence.
- Novartis AG: Announced promising results from a Phase 3 clinical trial for an SMA drug in 2023.
- Pfizer Inc.: Entered into a strategic partnership with a genetic research institute in 2023 to advance SMA therapies.
Scope of the Report:
Global Spinal Muscular Atrophy Treatment Market, By Type
Global Spinal Muscular Atrophy Treatment Market, By Route of Administration
Global Spinal Muscular Atrophy Treatment Market, By Age Group
Global Spinal Muscular Atrophy Treatment Market, By End User
Global Spinal Muscular Atrophy Treatment Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
● F. Hoffmann-La Roche Ltd.
● Novartis AG
● Ionis Pharmaceuticals, Inc.
● Scholar Rock Holding Corporation
● NMD Phrama A/S
● Biogen
● Pfizer Inc.
● Hanugen Theraputics
● Cytokinetics
● Beijing Jinlan Gene Technology Co., Ltd.
● Other key players
*The report scope shall be customized as per the requirements
Chapter 1 Global Spinal Muscular Atrophy Treatment Market Overview
1.1 Introduction
1.2 Drivers for Spinal Muscular Atrophy Treatment Market
1.3 Restraints for Spinal Muscular Atrophy Treatment Market
1.4 Opportunities for Spinal Muscular Atrophy Treatment Market
1.5 Trends for Spinal Muscular Atrophy Treatment Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Spinal Muscular Atrophy Treatment Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 F. Hoffmann-La Roche Ltd.
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Novartis AG
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Ionis Pharmaceuticals, Inc.
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Scholar Rock Holding Corporation
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 NMD Phrama A/S
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Biogen
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Pfizer Inc.
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Hanugen Theraputics
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Cytokinetics
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Beijing Jinlan Gene Technology Co., Ltd.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Spinal Muscular Atrophy Treatment Market Overview
3.1 Global Spinal Muscular Atrophy Treatment Market Outlook (2017-2032)
3.1.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Spinal Muscular Atrophy Treatment Market by Region
3.2.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Spinal Muscular Atrophy Treatment Market by Type
3.3.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
3.3.2 Global Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Type, 2023–2032
3.3.3 Global Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Spinal Muscular Atrophy Treatment Market by Route of Administration
3.4.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
3.4.2 Global Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Route of Administration, 2023–2032
3.5 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Type
3.6.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
3.6.2 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
3.7 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Route of Administration
3.7.1 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
3.7.2 Global Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
3.8 Global Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Region
3.8.2 Global Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Type
3.8.3 Global Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Route of Administration
3.9 Global Spinal Muscular Atrophy Treatment Market Share Comparison 2017–2032
3.9.1 Global Spinal Muscular Atrophy Treatment Market Share by Region
3.9.2 Global Spinal Muscular Atrophy Treatment Market Share by Type
3.9.3 Global Spinal Muscular Atrophy Treatment Market Share by Route of Administration
Chapter 4 North America Spinal Muscular Atrophy Treatment Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Spinal Muscular Atrophy Treatment Market Outlook (2017-2032)
4.2.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Spinal Muscular Atrophy Treatment Market by Region
4.3.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Spinal Muscular Atrophy Treatment Market by Type
4.4.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
4.4.2 North America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Type, 2023–2032
4.4.3 North America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Spinal Muscular Atrophy Treatment Market by Route of Administration
4.5.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
4.5.2 North America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Route of Administration, 2023–2032
4.6 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Type
4.7.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
4.7.2 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
4.8 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Route of Administration
4.8.1 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
4.8.2 North America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
4.9 North America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Region
4.9.2 North America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Type
4.9.3 North America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Route of Administration
4.1 North America Spinal Muscular Atrophy Treatment Market Share Comparison 2017–2032
4.10.1 North America Spinal Muscular Atrophy Treatment Market Share by Region
4.10.2 North America Spinal Muscular Atrophy Treatment Market Share by Type
4.10.3 North America Spinal Muscular Atrophy Treatment Market Share by Route of Administration
Chapter 5 Europe Spinal Muscular Atrophy Treatment Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Spinal Muscular Atrophy Treatment Market Outlook (2017-2032)
5.2.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Spinal Muscular Atrophy Treatment Market by Region
5.3.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Spinal Muscular Atrophy Treatment Market by Type
5.4.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
5.4.2 Europe Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Type, 2023–2032
5.4.3 Europe Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Spinal Muscular Atrophy Treatment Market by Route of Administration
5.5.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
5.5.2 Europe Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Route of Administration, 2023–2032
5.6 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Type
5.7.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
5.7.2 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
5.8 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Route of Administration
5.8.1 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
5.8.2 Europe Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
5.9 Europe Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Region
5.9.2 Europe Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Type
5.9.3 Europe Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Route of Administration
5.1 Europe Spinal Muscular Atrophy Treatment Market Share Comparison 2017–2032
5.10.1 Europe Spinal Muscular Atrophy Treatment Market Share by Region
5.10.2 Europe Spinal Muscular Atrophy Treatment Market Share by Type
5.10.3 Europe Spinal Muscular Atrophy Treatment Market Share by Route of Administration
Chapter 6 Asia Pacific Spinal Muscular Atrophy Treatment Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Outlook (2017-2032)
6.2.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Spinal Muscular Atrophy Treatment Market by Region
6.3.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Spinal Muscular Atrophy Treatment Market by Type
6.4.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
6.4.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Type, 2023–2032
6.4.3 Asia Pacific Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Spinal Muscular Atrophy Treatment Market by Route of Administration
6.5.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
6.5.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Route of Administration, 2023–2032
6.6 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Type
6.7.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
6.7.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
6.8 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Route of Administration
6.8.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
6.8.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
6.9 Asia Pacific Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Type
6.9.3 Asia Pacific Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Route of Administration
6.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Share Comparison 2017–2032
6.10.1 Asia Pacific Spinal Muscular Atrophy Treatment Market Share by Region
6.10.2 Asia Pacific Spinal Muscular Atrophy Treatment Market Share by Type
6.10.3 Asia Pacific Spinal Muscular Atrophy Treatment Market Share by Route of Administration
Chapter 7 South America Spinal Muscular Atrophy Treatment Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Spinal Muscular Atrophy Treatment Market Outlook (2017-2032)
7.2.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Spinal Muscular Atrophy Treatment Market by Region
7.3.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Spinal Muscular Atrophy Treatment Market by Type
7.4.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
7.4.2 South America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Type, 2023–2032
7.4.3 South America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Spinal Muscular Atrophy Treatment Market by Route of Administration
7.5.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
7.5.2 South America Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Route of Administration, 2023–2032
7.6 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Type
7.7.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
7.7.2 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
7.8 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Route of Administration
7.8.1 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
7.8.2 South America Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
7.9 South America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Region
7.9.2 South America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Type
7.9.3 South America Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Route of Administration
7.1 South America Spinal Muscular Atrophy Treatment Market Share Comparison 2017–2032
7.10.1 South America Spinal Muscular Atrophy Treatment Market Share by Region
7.10.2 South America Spinal Muscular Atrophy Treatment Market Share by Type
7.10.3 South America Spinal Muscular Atrophy Treatment Market Share by Route of Administration
Chapter 8 Middle East and Africa Spinal Muscular Atrophy Treatment Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Outlook (2017-2032)
8.2.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Spinal Muscular Atrophy Treatment Market by Region
8.3.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Spinal Muscular Atrophy Treatment Market by Type
8.4.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2032)
8.4.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Type, 2023–2032
8.4.3 Middle East and Africa Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Spinal Muscular Atrophy Treatment Market by Route of Administration
8.5.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2032)
8.5.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Attractiveness Analysis by Route of Administration, 2023–2032
8.6 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Type
8.7.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2017-2023)
8.7.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Type (2024-2032)
8.8 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) by Route of Administration
8.8.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2017-2023)
8.8.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Value (US$ Mn) and Volume (Units) Comparison by Route of Administration (2024-2032)
8.9 Middle East and Africa Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Type
8.9.3 Middle East and Africa Spinal Muscular Atrophy Treatment Market Y-o-Y Growth Rate by Route of Administration
8.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Spinal Muscular Atrophy Treatment Market Share by Region
8.10.2 Middle East and Africa Spinal Muscular Atrophy Treatment Market Share by Type
8.10.3 Middle East and Africa Spinal Muscular Atrophy Treatment Market Share by Route of Administration
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
